Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Carpenter

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|April 1, 1988
Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trialE B Cox, C L Vogel, J T Carpenter, et al.
Annals of Internal Medicine|November 1, 1975
Mithramycin in the treatment of systemic mastocytosisM E Conrad, J T Carpenter, J N Todd, et al.
American Family Physician|May 1, 1984
Methods of nutritional support for hospitalized patientsS M Campbell, J T Carpenter, S R Dillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancerL Silvey, J T Carpenter, R H Wheeler, et al.
JAMA|October 20, 1978
Agranulocytosis associated with disopyramide therapyM E Conrad, W G Cumbie, D R Thrasher, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindredN O Atuk, C Stolle, J A Owen, et al.
Cancer Treatment Reports|September 1, 1986
Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group TrialJ T Carpenter, R V Smalley, M Raney, et al.
Cancer|July 1, 1982
Favorable factors in the adjuvant therapy of breast cancerJ T Carpenter, W A Maddox, H L Laws, et al.
Surgery, Gynecology & Obstetrics|October 1, 1979
Splenectomy for hematologic diseaseH L Laws, M W Burlingame, J T Carpenter, et al.
Methods of Information in Medicine|July 1, 1976
Clinical algorithms for cancer chemotherapy--systems for community-based consultant-extenders and oncology centersE Mesel, D D Wirtschafter, J T Carpenter, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|April 1, 1988
Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trialE B Cox, C L Vogel, J T Carpenter, et al.
Annals of Internal Medicine|November 1, 1975
Mithramycin in the treatment of systemic mastocytosisM E Conrad, J T Carpenter, J N Todd, et al.
American Family Physician|May 1, 1984
Methods of nutritional support for hospitalized patientsS M Campbell, J T Carpenter, S R Dillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancerL Silvey, J T Carpenter, R H Wheeler, et al.
JAMA|October 20, 1978
Agranulocytosis associated with disopyramide therapyM E Conrad, W G Cumbie, D R Thrasher, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindredN O Atuk, C Stolle, J A Owen, et al.
Cancer Treatment Reports|September 1, 1986
Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group TrialJ T Carpenter, R V Smalley, M Raney, et al.
Cancer|July 1, 1982
Favorable factors in the adjuvant therapy of breast cancerJ T Carpenter, W A Maddox, H L Laws, et al.
Surgery, Gynecology & Obstetrics|October 1, 1979
Splenectomy for hematologic diseaseH L Laws, M W Burlingame, J T Carpenter, et al.
Methods of Information in Medicine|July 1, 1976
Clinical algorithms for cancer chemotherapy--systems for community-based consultant-extenders and oncology centersE Mesel, D D Wirtschafter, J T Carpenter, et al.
Pageof 5